Published in Int J Mol Sci on September 30, 2015
Decorin: A Growth Factor Antagonist for Tumor Growth Inhibition. Biomed Res Int (2015) 0.82
Wound repair and regeneration. Nature (2008) 12.30
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (1998) 8.11
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science (2010) 6.01
Organ targeting in vivo using phage display peptide libraries. Nature (1996) 5.20
Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature (1990) 4.90
Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest (1992) 4.49
Proteoglycans as modulators of growth factor activities. Cell (1991) 4.45
Targeting of drugs and nanoparticles to tumors. J Cell Biol (2010) 4.07
Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol (2008) 4.05
Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell (2009) 4.02
Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature (1992) 3.96
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54
Muscle injuries: biology and treatment. Am J Sports Med (2005) 3.15
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest (1998) 2.65
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci U S A (2009) 2.41
Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem (2007) 1.96
Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev Cell (2013) 1.89
Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med (2014) 1.87
Fluorescent peptides highlight peripheral nerves during surgery in mice. Nat Biotechnol (2011) 1.73
Vascular zip codes in angiogenesis and metastasis. Biochem Soc Trans (2004) 1.65
Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation. Nature (1988) 1.62
The RGD story: a personal account. Matrix Biol (2003) 1.47
An address system in the vasculature of normal tissues and tumors. Annu Rev Immunol (2000) 1.41
Nanoparticle-induced vascular blockade in human prostate cancer. Blood (2010) 1.30
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int (2013) 1.30
Human CD34/CD90 ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries. PLoS One (2009) 1.29
Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science (2014) 1.27
Mapping of vascular ZIP codes by phage display. Methods Enzymol (2012) 1.21
Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapy. J Immunol (2012) 1.17
Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis. Arthritis Res Ther (2009) 1.12
Molecular profiling of heart endothelial cells. Circulation (2005) 1.11
Molecular changes in the vasculature of injured tissues. Am J Pathol (2007) 1.08
Tumor-penetrating peptides. Front Oncol (2013) 1.06
Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. Am J Pathol (2005) 1.05
Insulitis and islet microvasculature in type 1 diabetes. Histol Histopathol (1993) 1.04
Tumor vasculature targeting through NGR peptide-based drug delivery systems. Curr Pharm Biotechnol (2011) 0.97
Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice. Proc Natl Acad Sci U S A (2010) 0.97
Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity. J Biol Chem (2011) 0.96
Peptide-directed highly selective targeting of pulmonary arterial hypertension. Am J Pathol (2011) 0.93
Healing of a crush injury in rat striated muscle. 3. A micro-angiographical study of the effect of early mobilization and immobilization on capillary ingrowth. Acta Pathol Microbiol Scand A (1976) 0.93
Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases. FASEB J (2013) 0.88
Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell. J Drug Target (2011) 0.87
A novel vascular homing peptide strategy to selectively enhance pulmonary drug efficacy in pulmonary arterial hypertension. Am J Pathol (2014) 0.85
Quantity and accessibility for specific targeting of receptors in tumours. Sci Rep (2014) 0.84
Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse. Arthritis Res Ther (2013) 0.84
In vivo proteomic imaging analysis of caveolae reveals pumping system to penetrate solid tumors. Nat Med (2014) 0.83
Decorin: A Growth Factor Antagonist for Tumor Growth Inhibition. Biomed Res Int (2015) 0.82
Extracellular matrix-inspired growth factor delivery systems for bone regeneration. Adv Drug Deliv Rev (2015) 0.81
Targeted Antiscarring Therapy for Tissue Injuries. Adv Wound Care (New Rochelle) (2013) 0.80
Peptide-coated liposomal fasudil enhances site specific vasodilation in pulmonary arterial hypertension. Mol Pharm (2014) 0.79
Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension. J Pharm Sci (2014) 0.79
SDF-1/54-DCN: a novel recombinant chimera with dual inhibitory effects on proliferation and chemotaxis of tumor cells. Biol Pharm Bull (2008) 0.79
Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectin. Int J Cardiol (2015) 0.79
A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate. Isr Med Assoc J (2014) 0.78
Deep vascular imaging in wounds by two-photon fluorescence microscopy. PLoS One (2013) 0.78
Angiopep-conjugated nanoparticles for targeted long-term gene therapy of Parkinson's disease. Pharm Res (2013) 0.78
Fasudil and SOD packaged in peptide-studded-liposomes: Properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs. Int J Pharm (2015) 0.77
Design of target-seeking antifibrotic compounds. Methods Enzymol (2012) 0.76
Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs. J Clin Pharmacol (2015) 0.76
Cell permeable peptide conjugated nanoerythrosomes of fasudil prolong pulmonary arterial vasodilation in PAH rats. Eur J Pharm Biopharm (2014) 0.76